Raxibacumab

Specification

• Cat#: THA-0052
• Product Name: Raxibacumab
• Description: Raxibacumab is a monoclonal antibody used in conjunction with an antibacterial regimen to treat patients with inhalational anthrax caused by Bacillus anthracis and for prophylaxis of inhalational anthrax when appropriate.
• Sequences: Not Available
• Molecular Weight: 142844.5367 Da
• Introduction: Raxibacumab is a human IgG1λ monoclonal antibody that binds the protective antigen (PA) component of B. anthracis toxin. Raxibacumab has a molecular weight of approximately 146 kilodaltons. Raxibacumab is produced by recombinant DNA technology in a murine cell expression system. FDA approved on December 14, 2012.
• Purity: >99% by SDS-Page and HPLC analysis
• Formula: C6320H9794N1702O1998S42
• Appearance: Liquid
• Endotoxin Level: < 0.001 EU/μg of the protein by the LAL method

Pharmaceutical Information

• Pharmacodynamics: Not Available
• Targets: Protective antigen